Current treatment paradigms for lupus nephritis offer significant room for improvement, according to a presenter at the ...

Membranous glomerulonephritis (MGN ... You may need to make changes in your diet, such as reducing your intake of salt and protein. And you might need to take medication to help regulate your ...

Choosing a healthy lifestyle with plenty of exercise, quality sleep, and a well-rounded diet can reduce the risk of glomerulonephritis as well as the risk of other infections and hypertension.

Lupus nephritis is a serious complication of lupus that is caused by inflammation of the kidneys. It affects up to 60% of people with lupus and usually occurs within 5 years of diagnosis. If left ...

Lupus nephritis frequently recurs in the transplanted kidney, sometimes without clinical signs. Lupus nephritis frequently recurs after kidney transplantation, and it may be clinically quiescent ...

Therapy should include either belimumab or a calcineurin inhibitor, plus one or more conventional medications such as corticosteroids, cyclophosphamide, and/or a mycophenolic acid analog (e.g., ...

Treating lupus nephritis to achieve sustained remission for at least 3 years likely protects kidney function. In patients with active lupus nephritis, at least 3 years of sustained clinical ...

Glomerulonephritis leading to severe proteinuria, chronic renal failure and end-stage renal disease remains one of the most severe complications of systemic lupus erythematosus and is associated ...

Urinary neutrophil gelatinase-associated lipocalin (NGAL) level may predict disease activity in adult patients with lupus nephritis, according to new findings. “We found that levels of NGAL in ...

It is currently being tested against acute graft-vs-host disease (aGVHD), lupus nephritis, and uncontrolled asthma. Itolizumab is being tested in clinical trials in acute graft-vs-host disease ...